普利制药 (300630.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(普利制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
单季度财务指标:
 单季度销售毛利率(%) 64.0068.0072.0032.0078.0072.0080.00
 单季度销售净利率(%) 26.0029.0037.00-8.0029.0029.0044.00
 单季度净资产收益率ROE(%) 4.004.005.00-1.006.005.006.00
 单季度总资产净利率ROA(%) 2.002.002.00-1.003.002.003.00
单季度财务摘要:
 单季度营业总收入(元) 518,193,842.00460,874,060.00373,166,292.00435,653,366.00575,087,948.00427,677,767.00367,925,506.00
 单季度营业总成本(元) 383,575,609.00341,839,759.00243,515,781.00481,100,193.00382,311,162.00306,648,248.00212,061,775.00
 单季度营业收入(元) 518,193,842.00460,874,060.00373,166,292.00435,653,366.00575,087,948.00427,677,767.00367,925,506.00
 单季度营业利润(元) 132,971,588.00138,528,377.00139,489,924.00-31,272,113.00171,622,541.00131,381,171.00167,770,281.00
 单季度利润总额(元) 132,832,380.00138,595,980.00139,509,242.00-31,959,999.00171,694,637.00131,393,627.00167,788,247.00
 单季度净利润(元) 134,354,740.00131,512,474.00138,433,086.00-34,848,423.00167,852,735.00125,833,428.00161,777,968.00
 单季度归属母公司股东的净利润(元) 134,354,740.00131,512,474.00138,433,086.00-34,848,423.00167,852,735.00125,833,428.00161,777,968.00
 单季度经营活动产生的现金流量(元) -43,106,873.0044,819,069.0028,782,866.00452,109,116.0011,174,000.0048,735,906.0022,275,788.00
 单季度投资活动产生的现金流量(元) -29,544,642.00-219,194,103.00-380,887,182.00-120,067,450.00-160,972,126.00-478,864,690.00-215,463,508.00
 单季度筹资活动产生的现金流量(元) 46,462,097.0011,997,771.00137,236,826.00265,677,608.00-41,068,252.00293,340,674.00224,921,521.00
 单季度现金及现金等价物净增加(元) -26,278,720.00-160,138,382.00-214,777,883.00600,421,486.00-189,077,312.00-136,788,110.0031,733,802.00

前瞻产业研究院